Abbott Laboratories (NYSE:ABT – Free Report) had its price objective lowered by Citigroup from $128.00 to $119.00 in a research note published on Wednesday, Benzinga reports. The brokerage currently has a buy rating on the healthcare product maker’s stock. A number of other equities research analysts also recently issued reports on the company. Barclays lowered […]
Linscomb & Williams Inc. lowered its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.6% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 104,319 shares of the healthcare product maker’s stock after selling 1,733 shares during the period. Abbott Laboratories makes […]
Glassman Wealth Services raised its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 10.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,685 shares of the healthcare product maker’s stock after purchasing an additional 264 shares during […]
TCW Group Inc Acquires New Stake in Abbott Laboratories (NYSE:ABT) wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
Mark Sheptoff Financial Planning LLC trimmed its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 44,852 shares of the healthcare product maker’s stock after selling 600 shares during the period. […]